Skip to main content
Top
Published in: Diabetologia 11/2014

Open Access 01-11-2014 | Article

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study

Authors: Lian Engelen, Sabita S. Soedamah-Muthu, Johanna M. Geleijnse, Monika Toeller, Nish Chaturvedi, John H. Fuller, Casper G. Schalkwijk, Coen D. A. Stehouwer

Published in: Diabetologia | Issue 11/2014

Login to get access

Abstract

Aims/hypothesis

High dietary salt intake has been associated with elevated BP and may also have a deleterious effect on microvascular complications. We studied the cross-sectional associations between dietary salt intake (estimated from 24 h urinary sodium excretion) and urinary potassium excretion on the one hand, and the prevalence of microvascular complications on the other, in individuals with type 1 diabetes.

Methods

We measured sodium and potassium concentrations in two 24 h urine samples in 1,212 individuals with type 1 diabetes (40 ± 10 years old, 51% men) who participated in the EURODIAB Prospective Complications Study. We used multiple logistic regression analyses to investigate associations between dietary salt intake and microvascular complications adjusted for age and sex, and additionally for BMI, smoking, urinary potassium excretion, antihypertensive medication and physical activity, and total energy, protein, alcohol, saturated fat and fibre intake.

Results

After full adjustment, 1 g/day higher dietary salt intake was positively associated with the presence of microalbuminuria (OR 1.06 [95% CI 1.01, 1.10]), but not macroalbuminuria (OR 0.99 [95% CI 0.94, 1.05]), non-proliferative retinopathy (OR 1.00 (95% CI 0.96, 1.04]) or proliferative retinopathy (OR 1.02 (95% CI 0.95, 1.08]). After excluding individuals with cardiovascular disease and/or antihypertensive medication (n = 418), we found a non-significant association with microalbuminuria (OR 1.04 [95% CI 0.99, 1.10]) and macroalbuminuria (OR 1.05 [95% CI 0.96, 1.16]). The association between dietary salt intake and microalbuminuria was stronger in individuals with a BMI above 25 kg/m2 (OR 1.11 [95% CI 1.04, 1.18]) than in those with BMI below 25 kg/m2 (OR 1.03 [95% CI 0.97, 1.09]). No significant associations were found between urinary potassium excretion and microvascular complications.

Conclusions/interpretation

In individuals with type 1 diabetes, higher dietary salt intake, as determined by 24 h urinary sodium excretion, may be positively associated with microalbuminuria, particularly in overweight individuals.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bantle JP, Wylie-Rosett J, Albright AL et al (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl 1):S61–S78PubMed Bantle JP, Wylie-Rosett J, Albright AL et al (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl 1):S61–S78PubMed
2.
go back to reference Mann JI, de Leeuw I, Hermansen K et al (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394PubMedCrossRef Mann JI, de Leeuw I, Hermansen K et al (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394PubMedCrossRef
3.
go back to reference Kotchen TA, Cowley AW Jr, Frohlich ED (2013) Salt in health and disease—a delicate balance. N Engl J Med 368:1229–1237 Kotchen TA, Cowley AW Jr, Frohlich ED (2013) Salt in health and disease—a delicate balance. N Engl J Med 368:1229–1237
4.
go back to reference Daviglus ML, Greenland P, Stamler J et al (2005) Relation of nutrient intake to microalbuminuria in nondiabetic middle-aged men and women: International Population Study on Macronutrients and Blood Pressure (INTERMAP). Am J Kidney Dis 45:256–266PubMedCrossRef Daviglus ML, Greenland P, Stamler J et al (2005) Relation of nutrient intake to microalbuminuria in nondiabetic middle-aged men and women: International Population Study on Macronutrients and Blood Pressure (INTERMAP). Am J Kidney Dis 45:256–266PubMedCrossRef
5.
go back to reference Verhave JC, Hillege HL, Burgerhof JG et al (2004) Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256:324–330PubMedCrossRef Verhave JC, Hillege HL, Burgerhof JG et al (2004) Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256:324–330PubMedCrossRef
6.
go back to reference du Cailar G, Ribstein J, Mimran A (2002) Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 15:222–229PubMedCrossRef du Cailar G, Ribstein J, Mimran A (2002) Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 15:222–229PubMedCrossRef
7.
go back to reference Aaron KJ, Campbell RC, Judd SE, Sanders PW, Muntner P (2011) Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Clin Nutr 94:1071–1078PubMedCrossRefPubMedCentral Aaron KJ, Campbell RC, Judd SE, Sanders PW, Muntner P (2011) Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Clin Nutr 94:1071–1078PubMedCrossRefPubMedCentral
9.
go back to reference Fox CS, Larson MG, Hwang SJ et al (2006) Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int 69:2064–2069PubMedCrossRef Fox CS, Larson MG, Hwang SJ et al (2006) Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int 69:2064–2069PubMedCrossRef
10.
go back to reference Sakabe K, Fukui M, Ushigome E et al (2012) Low daily salt intake is correlated with albuminuria in patients with type 2 diabetes. Hypertens Res 35:1176–1179PubMedCrossRef Sakabe K, Fukui M, Ushigome E et al (2012) Low daily salt intake is correlated with albuminuria in patients with type 2 diabetes. Hypertens Res 35:1176–1179PubMedCrossRef
11.
go back to reference Thomas MC, Moran J, Forsblom C et al (2011) The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34:861–866PubMedCrossRefPubMedCentral Thomas MC, Moran J, Forsblom C et al (2011) The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34:861–866PubMedCrossRefPubMedCentral
12.
go back to reference Roy MS, Janal MN (2010) High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch Ophthalmol 128:33–39PubMedCrossRef Roy MS, Janal MN (2010) High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch Ophthalmol 128:33–39PubMedCrossRef
13.
go back to reference Adrogue HJ, Madias NE (2007) Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 356:1966–1978PubMedCrossRef Adrogue HJ, Madias NE (2007) Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 356:1966–1978PubMedCrossRef
14.
go back to reference Koivisto VA, Stevens LK, Mattock M et al (1996) Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care 19:689–697PubMedCrossRef Koivisto VA, Stevens LK, Mattock M et al (1996) Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care 19:689–697PubMedCrossRef
15.
go back to reference Stephenson F, Fuller JH, on behalf of the EURODIAB IDDM Complications Study Group (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278–285CrossRef Stephenson F, Fuller JH, on behalf of the EURODIAB IDDM Complications Study Group (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278–285CrossRef
16.
go back to reference Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH (2001) Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60:219–227PubMedCrossRef Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH (2001) Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60:219–227PubMedCrossRef
18.
go back to reference Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38:437–444PubMedCrossRef Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38:437–444PubMedCrossRef
19.
go back to reference Toeller M, Klischan A, Heitkamp G et al (1996) Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia 39:929–939PubMedCrossRef Toeller M, Klischan A, Heitkamp G et al (1996) Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia 39:929–939PubMedCrossRef
20.
go back to reference Brown IJ, Tzoulaki I, Candeias V, Elliott P (2009) Salt intakes around the world: implications for public health. Int J Epidemiol 38:791–813PubMedCrossRef Brown IJ, Tzoulaki I, Candeias V, Elliott P (2009) Salt intakes around the world: implications for public health. Int J Epidemiol 38:791–813PubMedCrossRef
21.
go back to reference Hunter D (1998) Biochemical indicators of dietary intake. In: Willet W (ed) Nutritional epidemiology. Oxford University Press, Oxford, pp 174–243 Hunter D (1998) Biochemical indicators of dietary intake. In: Willet W (ed) Nutritional epidemiology. Oxford University Press, Oxford, pp 174–243
22.
go back to reference Sterne JA, White IR, Carlin JB et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393PubMedCrossRefPubMedCentral Sterne JA, White IR, Carlin JB et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393PubMedCrossRefPubMedCentral
23.
go back to reference Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI (2007) Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 36:1111–1118PubMedCrossRef Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI (2007) Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 36:1111–1118PubMedCrossRef
24.
go back to reference Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CD (2002) Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study. Diabetes Care 25:2320–2327PubMedCrossRef Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CD (2002) Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study. Diabetes Care 25:2320–2327PubMedCrossRef
25.
go back to reference Rocchini AP, Key J, Bondie D et al (1989) The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580–585PubMedCrossRef Rocchini AP, Key J, Bondie D et al (1989) The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580–585PubMedCrossRef
26.
go back to reference Ribstein J, du Cailar G, Mimran A (1995) Combined renal effects of overweight and hypertension. Hypertension 26:610–615PubMedCrossRef Ribstein J, du Cailar G, Mimran A (1995) Combined renal effects of overweight and hypertension. Hypertension 26:610–615PubMedCrossRef
27.
go back to reference Stolarz-Skrzypek K, Kuznetsova T, Thijs L et al (2011) Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305:1777–1785PubMedCrossRef Stolarz-Skrzypek K, Kuznetsova T, Thijs L et al (2011) Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305:1777–1785PubMedCrossRef
28.
go back to reference O'Donnell MJ, Yusuf S, Mente A et al (2011) Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306:2229–2238PubMedCrossRef O'Donnell MJ, Yusuf S, Mente A et al (2011) Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 306:2229–2238PubMedCrossRef
30.
go back to reference Labarthe DR, Briss PA (2011) Urinary sodium excretion and cardiovascular disease mortality. JAMA 306:1084–1085, author reply 1086-1087PubMedCrossRef Labarthe DR, Briss PA (2011) Urinary sodium excretion and cardiovascular disease mortality. JAMA 306:1084–1085, author reply 1086-1087PubMedCrossRef
31.
go back to reference Cook NR, Appel LJ, Whelton PK (2014) Lower levels of sodium intake and reduced cardiovascular risk. Circulation 129:981–989PubMedCrossRef Cook NR, Appel LJ, Whelton PK (2014) Lower levels of sodium intake and reduced cardiovascular risk. Circulation 129:981–989PubMedCrossRef
32.
go back to reference Lambers Heerspink HJ, Kwakernaak A, de Zeeuw D, Navis G (2011) Comment on: Ekinci et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34:703–709, Diabetes Care 34:e124; author reply e125CrossRef Lambers Heerspink HJ, Kwakernaak A, de Zeeuw D, Navis G (2011) Comment on: Ekinci et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34:703–709, Diabetes Care 34:e124; author reply e125CrossRef
33.
go back to reference Lambert J, Pijpers R, van Ittersum FJ et al (1997) Sodium, blood pressure, and arterial distensibility in insulin-dependent diabetes mellitus. Hypertension 30:1162–1168PubMedCrossRef Lambert J, Pijpers R, van Ittersum FJ et al (1997) Sodium, blood pressure, and arterial distensibility in insulin-dependent diabetes mellitus. Hypertension 30:1162–1168PubMedCrossRef
34.
go back to reference Weir MR, Dengel DR, Behrens MT, Goldberg AP (1995) Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25:1339–1344PubMedCrossRef Weir MR, Dengel DR, Behrens MT, Goldberg AP (1995) Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25:1339–1344PubMedCrossRef
35.
go back to reference Marcovecchio ML, Dalton RN, Schwarze CP et al (2009) Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia 52:1173–1181PubMedCrossRef Marcovecchio ML, Dalton RN, Schwarze CP et al (2009) Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia 52:1173–1181PubMedCrossRef
36.
go back to reference Boddi M, Poggesi L, Coppo M et al (1998) Human vascular renin–angiotensin system and its functional changes in relation to different sodium intakes. Hypertension 31:836–842 Boddi M, Poggesi L, Coppo M et al (1998) Human vascular renin–angiotensin system and its functional changes in relation to different sodium intakes. Hypertension 31:836–842
38.
go back to reference Gavras I, Gavras H (2012) 'Volume-expanded' hypertension: the effect of fluid overload and the role of the sympathetic nervous system in salt-dependent hypertension. J Hypertens 30:655–659PubMedCrossRef Gavras I, Gavras H (2012) 'Volume-expanded' hypertension: the effect of fluid overload and the role of the sympathetic nervous system in salt-dependent hypertension. J Hypertens 30:655–659PubMedCrossRef
39.
go back to reference Lenda DM, Sauls BA, Boegehold MA (2000) Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol 279:H7–H14PubMed Lenda DM, Sauls BA, Boegehold MA (2000) Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol 279:H7–H14PubMed
40.
go back to reference Lastra G, Dhuper S, Johnson MS, Sowers JR (2010) Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol 7:577–584PubMedCrossRef Lastra G, Dhuper S, Johnson MS, Sowers JR (2010) Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol 7:577–584PubMedCrossRef
Metadata
Title
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study
Authors
Lian Engelen
Sabita S. Soedamah-Muthu
Johanna M. Geleijnse
Monika Toeller
Nish Chaturvedi
John H. Fuller
Casper G. Schalkwijk
Coen D. A. Stehouwer
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3367-9

Other articles of this Issue 11/2014

Diabetologia 11/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.